Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Depreciation & Amortization (CF) of $211000.0 for Q1 2026, up 5.5% year-over-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $212000.0 in Q4 2025.
Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Utah Medical Products' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $211000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 5.5% year-over-year to $211000.0; the TTM figure through Mar 2026 stood at $837000.0 (up 8.14% YoY), while the FY2025 annual figure was $826000.0, up 13.15% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $211000.0, roughly flat from $212000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $212000.0 in Q4 2025, with the low at $149000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $158000.0 (2022), against an average of $176588.2.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) dropped 8.59% in 2022, then soared 30.97% in 2024.
- Utah Medical Products' Depreciation & Amortization (CF) stood at $158000.0 in 2022, then changed by 0.0% to $158000.0 in 2023, then climbed by 26.58% to $200000.0 in 2024, then climbed by 6.0% to $212000.0 in 2025, then declined by 0.47% to $211000.0 in 2026.
- Business Quant data shows UTMD's Depreciation & Amortization (CF) at $211000.0 in Q1 2026, $212000.0 in Q4 2025, and $209000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210,000.00 |
| Jun 30, 2026 | 210,000.00 |
| Mar 31, 2026 | 211,000.00 |
| Mar 31, 2026 | 211,000.00 |
| Dec 31, 2025 | 212,000.00 |
| Dec 31, 2025 | 212,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Sep 30, 2025 | 209,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Mar 31, 2024 | 156,000.00 |